Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zangerle

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Therapies in HIV infection]R Zangerle
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Antiretroviral therapy 1998/1999: what is our current status?--Avoiding therapy failure instead of expecting it]R Zangerle
Current Problems in Dermatology|January 1, 1989
Candidiasis and the immunodeficient host: an updateR Zangerle, P Fritsch
Lancet (London, England)|December 15, 1990
Heterosexual transmission of HIV-1 in women in AustriaF Piribauer, R Zangerle
Lancet (London, England)|May 18, 1991
Effect of prophylaxis against Pneumocystis carinii on toxoplasma encephalitisR Zangerle, F Allerberger
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondiiR Zangerle, F Allerberger
AIDS Patient Care and Stds|May 22, 2001
Persistent flank pain, low-grade fever, and malaise in a woman treated with indinavirM Sarcletti, R Zangerle
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Guidelines for implementing antiretroviral therapy]M Sarcletti, R Zangerle
Lancet (London, England)|January 4, 1997
Absence of awareness of primary HIV infectionJ Möst, R Zangerle
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Immune activation markers and CD4+ T-cell counts in HIV-infected intravenous drug usersR Zangerle, H Wachter, D Fuchs
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Therapies in HIV infection]R Zangerle
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Antiretroviral therapy 1998/1999: what is our current status?--Avoiding therapy failure instead of expecting it]R Zangerle
Current Problems in Dermatology|January 1, 1989
Candidiasis and the immunodeficient host: an updateR Zangerle, P Fritsch
Lancet (London, England)|December 15, 1990
Heterosexual transmission of HIV-1 in women in AustriaF Piribauer, R Zangerle
Lancet (London, England)|May 18, 1991
Effect of prophylaxis against Pneumocystis carinii on toxoplasma encephalitisR Zangerle, F Allerberger
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondiiR Zangerle, F Allerberger
AIDS Patient Care and Stds|May 22, 2001
Persistent flank pain, low-grade fever, and malaise in a woman treated with indinavirM Sarcletti, R Zangerle
Wiener Medizinische Wochenschrift (1946)|April 6, 1999
[Guidelines for implementing antiretroviral therapy]M Sarcletti, R Zangerle
Lancet (London, England)|January 4, 1997
Absence of awareness of primary HIV infectionJ Möst, R Zangerle
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Immune activation markers and CD4+ T-cell counts in HIV-infected intravenous drug usersR Zangerle, H Wachter, D Fuchs
Pageof 8